News Archive - Page 4 of 7

Lifecare open position

May 4, 2022
For our development site in Reutlingen, Germany, we have an open position as: Technical research scientist / electrical engineer for Biomedical MEMS Main responsibilities will be: Taking responsibility for the measurement techniques, mainly, programming and interfacing the readout devices at our facilities in Germany (Reutlingen). Investigating low noise instrumentation/devices, implementing, and testing them on […]
Read more

Information from Lifecare – April 2022

April 4, 2022
Demonstration of nano-scale dispensing of biochemical solutions on the Sencell chip and an article in the Norwegian Technical Weekly. Upcoming events and an operational update. Read more below: Nanofluidics and assembly The Sencell Glucose sensor is based on a pre-produced silicon chip where Lifecare in the first step applies nano-scale pressure sensors and microelectronics. […]
Read more

Article Teknisk Ukeblad March 2022

March 22, 2022
CEO Joacim Holter was interviewed by the Norwegian Magazine Teknisk ukeblad in March 2022. Read more here (Norwegian only): Norsk teknologi kan gjøre livet lettere for diabetikere – Tu.no
Read more

Spotting Sencell video

March 21, 2022
March 10, 2022 we visited the bioinstrumention company GeSiM Gesellschaft fuer Silizium-Mikrosysteme mbH in Radeberg, Germany. GeSiM develops micro and nanoscale liquid handling instruments. In the video you can see a demonstration of how the chambers in the Sencell sensor can be filled with approximately 300 nanoliter of liquid, before glue is applied on the housing […]
Read more

Information from Lifecare – February 2022

February 28, 2022
Following the restructuring of Lifecare including the acquisition of the two operational German subsidiaries Lifecare NanoBioSensors and Lifecare Laboratories, the Lifecare Board of Directors, management, and key personnel have conducted an inspiring and productive workshop in Mainz, Germany. Due to a current high demand for Covid PCR testing, Lifecare Laboratories experiences an extraordinarily high activity […]
Read more

Lifecare open position

February 4, 2022
To oversee product development and initial preparations for production, in close collaboration with our R&D departments, Lifecare is looking for a Product Development Manager Main responsibilities Implementation and follow-up of Quality Management System Coordinate product development and production preparations in collaboration with the CSO. Support the coordination of regulatory studies in different locations. Read […]
Read more

Information from Lifecare – January 2022

January 31, 2022
The overall aim for Lifecare in 2022 is to initiate clinical activities in line with our development milestones. The planned activities will bring our unique Sencell osmotic sensing technology a significant step closer to regulatory approval as a medical device for diabetes care. Preparations to ensure a regulatory approved platform have been initiated and we […]
Read more

Information from Lifecare – December 2021

December 20, 2021
Development and preparations for first-in-human pilot study is on track as Lifecare successfully has manufactured nanogranular tunneling strain (NTR) sensors on the prototype Sencell electrodes at the new Lifecare NanoBioSensors laboratory. The manufacturing of NTR sensors is a major technical achievement for Lifecare. On the operational side, the Lifecare Board of Directors has approved the Share […]
Read more

Lifecare nominated to the Industrial Advisory Board at MARSS conference

October 14, 2021
Lifecare has been invited to take seat in the Industrial Advisory Board (IAB) at the 5th International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS) to be held in Toronto, Canada, Jul 18-22, 2022. Lifecare has accepted the invitation. MARSS is the flagship event for cross-disciplinary R&D communities to discuss current activities […]
Read more

Information from Lifecare – October 2021

October 12, 2021
Lifecare has successfully completed a private placement issuing new shares providing the company with NOK 26,3 million in gross proceeds. The price per offer share was set at market to NOK 1,70. The Lifecare Nanobiosensors MEMS & Sensor Research Laboratory in Reutingen (DE) is now operational and Lifecare has engaged Cambridge Consultants in Cambridge (UK) […]
Read more